CRT patterns and short-term outcomes on unresectable NSCLC in routine practices in Russia

Trial Identifier: D133HR00026
Sponsor: AstraZeneca
Start Date: March 2023
Primary Completion Date: December 2025
Study Completion Date: December 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Grozny, Russia
Russia Irkutsk, Russia
Russia Kostroma, Russia
Russia Sochi, Russia
Russia Yuzhno-Sakhalinsk, Russia